Capital Research Global Investors Johnson & Johnson Transaction History

Capital Research Global Investors

  • $463 Billion
  • Q3 2024

A detailed history of Capital Research Global Investors transactions in Johnson & Johnson stock. As of the latest transaction made, Capital Research Global Investors holds 1,142,084 shares of JNJ stock, worth $167 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,142,084
Previous 1,141,138 0.08%
Holding current value
$167 Million
Previous $167 Million 10.97%
% of portfolio
0.04%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$145.48 - $167.38 $137,624 - $158,341
946 Added 0.08%
1,142,084 $185 Million
Q2 2024

Aug 13, 2024
BUY
$144.38 - $157.78 $72.9 Million - $79.7 Million
505,000 Added 79.39%
1,141,138 $167 Million
Q1 2024

May 14, 2024
BUY
$155.22 - $162.74 $50,136 - $52,565
323 Added 0.05%
636,138 $101 Million
Q4 2023

Feb 13, 2024
SELL
$145.6 - $158.88 $4,513 - $4,925
-31 Reduced -0.0%
635,815 $99.7 Million
Q3 2023

Nov 13, 2023
SELL
$155.75 - $174.48 $29.9 Million - $33.5 Million
-191,936 Reduced 23.19%
635,846 $99 Million
Q2 2023

Aug 11, 2023
BUY
$154.35 - $166.11 $56,492 - $60,796
366 Added 0.04%
827,782 $137 Million
Q1 2023

May 15, 2023
SELL
$151.05 - $180.26 $127 Million - $152 Million
-843,135 Reduced 50.47%
827,416 $128 Million
Q3 2022

Nov 14, 2022
BUY
$161.33 - $179.52 $136 Million - $151 Million
843,394 Added 101.96%
1,670,551 $273 Million
Q2 2022

Aug 15, 2022
SELL
$168.19 - $186.01 $37,338 - $41,294
-222 Reduced 0.03%
827,157 $147 Million
Q1 2022

May 16, 2022
BUY
$158.14 - $179.59 $3,004 - $3,412
19 Added 0.0%
827,379 $147 Million
Q4 2021

Feb 14, 2022
SELL
$155.93 - $173.01 $30,250 - $33,563
-194 Reduced 0.02%
827,360 $142 Million
Q3 2021

Nov 15, 2021
BUY
$161.5 - $179.47 $28,101 - $31,227
174 Added 0.02%
827,554 $134 Million
Q2 2021

Aug 16, 2021
SELL
$159.48 - $171.07 $96.3 Million - $103 Million
-603,571 Reduced 42.18%
827,380 $136 Million
Q1 2021

May 14, 2021
SELL
$153.07 - $170.48 $918 - $1,022
-6 Reduced -0.0%
1,430,951 $235 Million
Q4 2020

Feb 12, 2021
SELL
$137.11 - $157.38 $99.4 Million - $114 Million
-725,177 Reduced 33.63%
1,430,957 $225 Million
Q3 2020

Nov 13, 2020
SELL
$140.38 - $153.83 $58,538 - $64,147
-417 Reduced 0.02%
2,156,134 $321 Million
Q2 2020

Aug 14, 2020
SELL
$128.81 - $155.51 $6.53 Million - $7.89 Million
-50,725 Reduced 2.3%
2,156,551 $303 Million
Q1 2020

May 15, 2020
SELL
$111.14 - $153.99 $76.8 Million - $106 Million
-691,374 Reduced 23.85%
2,207,276 $289 Million
Q4 2019

Feb 18, 2020
BUY
$127.5 - $146.44 $199,665 - $229,325
1,566 Added 0.05%
2,898,650 $423 Million
Q3 2019

Nov 14, 2019
SELL
$126.95 - $142.14 $133 Million - $149 Million
-1,050,414 Reduced 26.61%
2,897,084 $375 Million
Q2 2019

Aug 14, 2019
SELL
$131.15 - $144.24 $286 Million - $315 Million
-2,181,998 Reduced 35.6%
3,947,498 $550 Million
Q1 2019

May 15, 2019
SELL
$125.72 - $139.79 $14,206 - $15,796
-113 Reduced -0.0%
6,129,496 $857 Million
Q4 2018

Feb 14, 2019
BUY
$122.84 - $147.84 $76.5 Million - $92.1 Million
622,705 Added 11.31%
6,129,609 $791 Million
Q3 2018

Nov 14, 2018
SELL
$121.58 - $142.88 $154 Million - $181 Million
-1,270,099 Reduced 18.74%
5,506,904 $761 Million
Q2 2018

Aug 14, 2018
SELL
$119.4 - $131.76 $89.3 Million - $98.5 Million
-747,594 Reduced 9.94%
6,777,003 $822 Million
Q1 2018

May 15, 2018
BUY
$125.1 - $148.14 $72.7 Million - $86 Million
580,853 Added 8.37%
7,524,597 $964 Million
Q4 2017

Feb 14, 2018
BUY
$131.22 - $143.62 $40 Million - $43.8 Million
305,029 Added 4.59%
6,943,744 $970 Million
Q3 2017

Nov 14, 2017
BUY
$129.47 - $135.38 $860 Million - $899 Million
6,638,715
6,638,715 $863 Million

Others Institutions Holding JNJ

# of Institutions
4,275
Shares Held
1.68B
Call Options Held
17.6M
Put Options Held
14.5M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $383B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Capital Research Global Investors Portfolio

Follow Capital Research Global Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email